IN-DATE
S1.1490: FCI Ritleng Lacrimal Bicanaliculus Intubation Set, Silicone + PVP, 300mm, 0.64mm
Sign in to add this product to your favorites!
| Price: | $5.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 12 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 13 hours 46 minutes and choose overnight shipping at checkout. |
Additional Details
FCI Ophthalmics Ritleng Lacrimal Bicanaliculus Intubation
Ritleng® is FCI’s autostable, bicanalicular, nasolacrimal intubation system indicated for epiphora, canalicular pathologies, congenital nasolacrimal duct obstruction and dacryocystorhinostomy (DCR). It consists of a silicone (or PVP) tube connected at each extremity to a black PolyEtherEtherKetone (PEEK) thread guide.
Product Code: S1.1490U / S1.1491U
- For lacrimal duct stenosis, canalicular laceration, DCR
- Silicone, Black PEEK (PolyEtherEtherKetone)
- PVP
- Thread-Guide Silicone tubing (L: 300 mm, Diam: 0.64 mm)
- REQUIRES: Ritleng Probe S1-1460U and Ritleng Hook S1-1480U
Additional Details
- Company Name: FCI Ophthalmics
- FDA Product Code: OKS
- FDA Product Code Name: Lacrimal Stents And Intubation Sets
- GMDN Term Code: 17003
- GMDN Term Name: Lacrimal Tube
- GMDN Term Definition: An implantable short tube intended to provide a bypass route for tear drainage from the corner of the eye into the nasal cavity, or a paranasal sinus, as treatment for pathologies of the tear drainage system in association with functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent (e.g., Lester Jones type), it is implanted after surgery to dilate or maintain a surgically-created passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer materials (e.g., silicone).
AccessGUDID Info
- FDA Product Code: OKS
- FDA Product Code Name: Lacrimal Stents And Intubation Sets
- GMDN Term Code: 17003
- GMDN Term Name: Lacrimal tube
- GMDN Term Description: An implantable short tube intended to provide a bypass route for tear drainage from the corner of the eye into the nasal cavity, or a paranasal sinus, as treatment for pathologies of the tear drainage system in association with functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent (e.g., Lester Jones type), it is implanted after surgery to dilate or maintain a surgically-created passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer materials (e.g., silicone).
Manufacturer
FCI Ophthalmics is a specialty medical device company focused on developing and supplying innovative surgical products for ophthalmology, particularly in the areas of oculoplastics, lacrimal surgery, and retina. The company offers a broad portfolio that includes lacrimal stents and intubation systems, orbital implants, eyelid weights, punctal plugs, and devices for retinal and vitreoretinal procedures. Known for products like the Monoka stent, the BIKA intubation system, and the TearStim dry eye treatment device, FCI supports ophthalmic surgeons with precise, minimally invasive solutions designed to restore function and improve patient comfort in both reconstructive and functional eye surgeries.
